J G de Yebenes - JoVE Visualize

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Acta Neurologica Scandinavica|April 1, 1984

Monoamine metabolites in human cerebrospinal fluid. HPLC/ED methodM A Mena, E G Aguado, J G de Yebenes

Clinical Neuropharmacology|April 1, 1988

Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivityS Giménez-Roldán, D Mateo, V Muradas, et al.

Polish Journal of Pharmacology|September 1, 1994

Intrastriatal infusion of amiloride increases rotations in 6-OHDA lesioned rats and "down-regulates" D2 receptors in the striatum and 5-HT2A receptors in the cortexZ Jamrozik, J G De Yebenes, D D Troung, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987

The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiencyJ G de Yebenes, S Fahn, V Jackson-Lewis, et al.

Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994

Effects of retinoic acid on NB 69 human neuroblastoma cells and fetal rat mid brain neuronsM A Mena, M J Casarejos, C Estrada, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1995

The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's diseaseW D Neira, V Sanchez, M A Mena, et al.

Neuroreport|April 1, 1993

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acidM A Mena, B Pardo, C L Paino, et al.

Neurology|January 1, 1990

Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.

Current Medicinal Chemistry|October 16, 2008

On the pathogenesis and neuroprotective treatment of Parkinson disease: what have we learned from the genetic forms of this disease?M A Mena, J A Rodriguez-Navarro, R Ros, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986

The effect of single and repeated administration of bromocriptine on monoamine metabolism in rat brain and [3H]spiroperidol binding to striatal membranesV Muradas, E Bazan, J J Gervas, et al.

Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Acta Neurologica Scandinavica|April 1, 1984

Monoamine metabolites in human cerebrospinal fluid. HPLC/ED methodM A Mena, E G Aguado, J G de Yebenes

Clinical Neuropharmacology|April 1, 1988

Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivityS Giménez-Roldán, D Mateo, V Muradas, et al.

Polish Journal of Pharmacology|September 1, 1994

Intrastriatal infusion of amiloride increases rotations in 6-OHDA lesioned rats and "down-regulates" D2 receptors in the striatum and 5-HT2A receptors in the cortexZ Jamrozik, J G De Yebenes, D D Troung, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987

The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiencyJ G de Yebenes, S Fahn, V Jackson-Lewis, et al.

Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994

Effects of retinoic acid on NB 69 human neuroblastoma cells and fetal rat mid brain neuronsM A Mena, M J Casarejos, C Estrada, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1995

The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's diseaseW D Neira, V Sanchez, M A Mena, et al.

Neuroreport|April 1, 1993

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acidM A Mena, B Pardo, C L Paino, et al.

Neurology|January 1, 1990

Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.

Current Medicinal Chemistry|October 16, 2008

On the pathogenesis and neuroprotective treatment of Parkinson disease: what have we learned from the genetic forms of this disease?M A Mena, J A Rodriguez-Navarro, R Ros, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986

The effect of single and repeated administration of bromocriptine on monoamine metabolism in rat brain and [3H]spiroperidol binding to striatal membranesV Muradas, E Bazan, J J Gervas, et al.

Pageof 2